Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A botanical drug, WH-1, has been approved for US FDA Phase II clinical trials for the treatment of diabetic foot ulcers and also potentially indicated for similar chronic wound healing management conditions. More
The University of Edinburgh has discovered a binding site for zinc in human albumin. More
VEGF111, a novel naturally occurring isoform of human VEGF-A, was recently cloned. VEGF111 is active in terms of activation of VEGF receptors, induction of endothelial cells multiplication and stimulation of vascularisation in vitro and in vivo. As r More
ω-conopeptide FVIA recently has developed an innovative pharmaceutical composition for preventing or treating diseases, disorders or conditions associated with N-type calcium channel activity More
Using a groundbreaking technique developed in astronomy, researchers at the University of Edinburgh are able to register complete 3D image volumes to sub-pixel accuracy in real-time More
The cultured autologous squamous epithelium, which differentiates into mucociliary epithelium after in vivo grafting, are remarkably effective in airway luminal reconstruction. More
Researchers at the University of Edinburgh have developed screening techniques that are able to identify if a patient has been exposed to a multiple organ failure initiating event, or is likely to develop multiple organ failure. More
Pharmacology and medical therapeutics of statins More
The invention relates to methods of quickly and accurately diagnosing renal cellular carcinoma (RCC) and monitoring renal tissue health as well as RCC treatment. More
Protection against tissue injury from a variety of causes More
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Accident & Trauma (other)
- Back Pain
- Bone fractures
- Burns
- CNS trauma
- Drug overdose
- Hemorraghic trauma
- Muscle sprain/strain
- Poisioning
- Reperfusion injury (lung/heart)
- Stroke/traumatic brain injury
- Tissue grafting
- Wound closure/surgical adhesive
- Wound/ulcer healing
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us